Back

Utility of post-procedural anticoagulation after primary percutaneous coronary intervention for STEMI: cardiac magnetic resonance and 2D-echocardiographic findings

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Interventional cardiology - General aspects Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Pil-Sang Song

Chungnam National University Hospital, Daejeon (Korea (Republic of))

11 More presentations in this session

Presentation thumbnail
Women in medicine: addressing the gender gap in interventional cardiology in Australia and New Zealand
Doctor S. Burgess (Sydney, AU)
Abstract Slides
Presentation thumbnail
Predictors for angiographic edge restenosis of 2nd generation drug-eluting stents: Integrated angiographic analyses from the post-marketing surveillance studies of everolimus-eluting stents in Japan
Professor K. Kozuma (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Do women benefit from bilateral internal mammary artery bypass grafting?
Miss F. Saraiva (Porto, PT)
Abstract
Presentation thumbnail
Utilizing telemedicine platforms to construct population-based AMI management - Results from half a million patient encounters in Latin America Telemedicine Infarct Network (LATIN)
Doctor S. Mehta (Miami, US)
Abstract Slides
Presentation thumbnail
Duration of dual anti platelet therapy in elective drug coated balloon angioplasty
Doctor N. Corballis (Norwich, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Interventional cardiology - General aspects

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources